Validation of a procedure to assess ASA-response in patients with decreased, initial TRAP induced aggregation

Platelets

Volumn 21, Issue 5, 2010, Pages 314-319

  Boeer, K ^a   Reinhofer M ^a   Losche W ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Aggregation; Arachidonic acid; ASS; Standardization; Thrombin; Thrombocyte

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; THROMBIN RECEPTOR ACTIVATING PEPTIDE 6; ANTITHROMBOCYTIC AGENT; OLIGOPEPTIDE; SER-PHE-PHE-LEU-ARG-ASN;

ARTICLE; BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DRUG MONITORING; DRUG RESPONSE; HEMATOLOGICAL PROCEDURES; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PNEUMATIC TOOL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SHEAR STRESS; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; VALIDATION PROCESS; WHOLE BLOOD AGGREGOMETRY; DRUG EFFECTS; IMPEDANCE; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ARACHIDONIC ACID; ASPIRIN; BLOOD PLATELETS; ELECTRIC IMPEDANCE; HUMANS; OLIGOPEPTIDES; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES;

EID: 77954802935     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537101003763442     Document Type: Article

References (24)

1. Seyfert UT, Haubelt H, Vogt A, Hellstern P. Variables influencing Multiplate(TM) whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals. Platelets 2007;18:199-206.
2. Kalb ML, Potura L, Scharbert G, Kozek-Langenecker SA. The effect of ex vivo anticoagulants on whole blood platelet aggregation. Platelets 2009;20:7-11.
3. Scharf RE. [Acquired platelet function disorders: Pathogenesis, classification, frequency, diagnosis, clinical management]. Hamostaseologie 2008;28:299-311.
4. Schafer A, Bauersachs J. Endothelial dysfunction, impaired endogenous platelet inhibition and platelet activation in diabetes and atherosclerosis. Curr Vasc Pharmacol 2008; 6:52-60.
5. Ziegelstein RC, Parakh K, Sakhuja A, Bhat U. Platelet function in patients with major depression. Intern Med J 2009;39:38-43.
6. Danese S, Motte Cd Cde L, Fiocchi C. Platelets in inflammatory bowel disease: Clinical, pathogenic, and therapeutic implications. Am J Gastroenterol 2004;99:938-945.
7. Levi M. Platelets in sepsis. Hematology 2005; 10(Suppl 1):129-131.
8. Cattaneo M, Hayward CP, Moffat KA, Pugliano MT, Liu Y, Michelson AD. Results of a Worldwide survey on the assessment of platelet function by light transmission aggregometry: A report from the platelet physiology subcommittee of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009;7:1029.
9. Harrison P, Frelinger 3rd AL, Furman MI, Michelson AD. Measuring antiplatelet drug effects in the laboratory. Thromb Res 2007;120:323-336.
10. Kuliczkowski W, Witkowski A, Polonski L, Watala C, Filipiak K, Budaj A, Golanski J, Sitkiewicz D, Pregowski J, Gorski J, et al. Interindividual variability in the response to oral antiplatelet drugs: A position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J 2009;30:426-435.
11. Sibbing D, Braun S, Jawansky S, Vogt W, Mehilli J, Schomig A, Kastrati A, von Beckerath N. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thromb Haemost 2008;99:121-126.
12. Toth O, Calatzis A, Penz S, Losonczy H, Siess W. Multiple electrode aggregometry: A new device to measure platelet aggregation in whole blood. Thromb Haemost 2006; 96:781-788.
13. Velik-Salchner C, Maier S, Innerhofer P, Streif W, Klingler A, Kolbitsch C, Fries D. Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: The results of a pilot study. Anesth Analg 2008; 107:1798-1806.
14. von Pape KW, Dzijan-Horn M, Bohner J, Spannagl M, Weisser H, Calatzis A. Control of aspirin effect in chronic cardiovascular patients using two whole blood platelet function assays. PFA-100 and Multiplate. Hamostaseologie 2007;27:155-160; 61-62.
15. Armstrong PC, Truss NJ, Ali FY, Dhanji AA, Vojnovic I, Zain ZN, Bishop-Bailey D, Paul-Clark MJ, Tucker AT, Mitchell JA, et al. Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2. J Thromb Haemost 2008;6:1933-1943.
16. Aursnes I, Vikholm V. On a possible interaction between ADP and mechanical stimulation in platelet activation. Thromb Haemost 1984;51:54-56.
17. Sodi R, Darn SM, Stott A. Pneumatic tube system induced haemolysis: Assessing sample type susceptibility to haemolysis. Ann Clin Biochem 2004;41:237-240.
18. Goldsmith HL, Bell DN, Braovac S, Steinberg A, McIntosh F. Physical and chemical effects of red cells in the shear-induced aggregation of human platelets. Biophys J 1995;69:1584-1595.
19. Aursnes I, Sundal J, Nome T. Shear stress activation of platelets with subsequent refractoriness. Thromb Res 1987; 45:29-37.
20. Kratz A, Salem RO, Van Cott EM. Effects of a pneumatic tube system on routine and novel hematology and coagulation parameters in healthy volunteers. Arch Pathol Lab Med 2007;131:293-296.
21. Dyszkiewicz-Korpanty A, Quinton R, Yassine J, Sarode R. The effect of a pneumatic tube transport system on PFA-100 trade mark closure time and whole blood platelet aggregation. J Thromb Haemost 2004;2:354-356.
22. Bolliger D, Seeberger MD, Tanaka KA, Dell-Kuster S, Gregor M, Zenklusen U, Grapow M, Tsakiris DA, Filipovic M. Pre-analytical effects of pneumatic tube transport on impedance platelet aggregometry. Platelets 2009;20:458-465.
23. Santilli F, Rocca B, De Cristofaro R, Lattanzio S, Pietrangelo L, Habib A, Pettinella C, Recchiuti A, Ferrante E, Ciabattoni G, et al. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: Implications for aspirin ''resistance''. J Am Coll Cardiol 2009;53:667-677.
24. Guthikonda S, Lev EI, Patel R, DeLao T, Bergeron AL, Dong JF, Kleiman NS. Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin. J Thromb Haemost 2007;5:490-496.